Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Saving bladders with brachytherapy: implantation technique and resultsElzbieta M Van der Steen-Banasik, Andries G Visser, Janny G Reinders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2009
Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands studyElzbieta van der Steen-Banasik, Martine Ploeg, Johannes A Witjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trialsVera Oppedijk, Ate van der Gaast, Jan J B van Lanschot, et al.
Lancet (London, England)|October 27, 2004
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trialMarjolein Y V Homs, Ewout W Steyerberg, Wilhelmina M H Eijkenboom, et al.
Annals of Surgery|November 8, 2014
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survivalA Koen Talsma, Joel Shapiro, Caspar W N Looman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, et al.
The Lancet. Oncology|August 10, 2015
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialJoel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS TrialBo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, et al.
Pageof 1